IPCALAB

Ipca Laboratories Share Price Ipca Laboratories

₹1,237.4
32.1 (2.66%)
  • Advice
  • Hold
29 March, 2024 02:17 BSE: 524494 NSE: IPCALABISIN: INE571A01038

Start SIP in Ipca Laboratories

Start SIP

Ipca Laboratories Performance

Day Range

  • Low 1,202
  • High 1,245
₹ 1,237

52 Week Range

  • Low 670
  • High 1,264
₹ 1,237
  • Open Price1,205
  • Previous Close1,205
  • Volume668011

Ipca Laboratories Share Price

  • Over 1 Month 4.13%
  • Over 3 Month 12.52%
  • Over 6 Month 33.93%
  • Over 1 Year 56.33%

Ipca Laboratories Key Statistics

P/E Ratio 55.6
PEG Ratio 7.4
Market Cap Cr 31,393
Price to Book Ratio 5.3
EPS 19.2
Dividend 0.2
Relative Strength Index 62.85
Money Flow Index 78.04
MACD Signal 2.16
Average True Range 38.51
Ipca Laboratories Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,5071,6631,4891,402
Operating Expenses Qtr Cr 1,2331,3541,1911,226
Operating Profit Qtr Cr 273309298176
Depreciation Qtr Cr 63616059
Interest Qtr Cr 27393118
Tax Qtr Cr 63838347
Net Profit Qtr Cr 13716216785
IndicatorMar 2023
Total Revenue Annual Cr 5,926
Operating Expenses Annual Cr 4,903
Operating Profit Annual in Cr 912
Depreciation Cr 229
Interest Annual Cr 44
Tax Annual Cr 245
Net Profit Annual Cr 506
IndicatorMar 2023
Cash from Operating Activity Annual Cr 762
Cash from Investing Activity Annual Cr -710
Cash from Financing Annual Activity Cr 506
Net Cash Flow Annual Cr 559
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 5,877
Fixed Assets Annual Cr 2,602
Total Non Current Assets Annual Cr 3,572
Total Current Assets Annual Cr 4,875
Total Assets Annual Cr 8,447
IndicatorMar 2023
Book Value Per Share Annual Rs 232
ROE Annual % 9
ROCE Annual % 12
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 18
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 2,0532,0341,5881,512
Operating Expenses Qtr Cr 1,7221,7131,2801,331
Operating Profit Qtr Cr 331321308181
Depreciation Qtr Cr 100906970
Interest Qtr Cr 33443118
Tax Qtr Cr 66888648
Net Profit Qtr Cr 18014516377
IndicatorMar 2023
Total Revenue Annual Cr 6,370
Operating Expenses Annual Cr 5,318
Operating Profit Annual in Cr 927
Depreciation Cr 262
Interest Annual Cr 46
Tax Annual Cr 253
Net Profit Annual Cr 471
IndicatorMar 2023
Cash from Operating Activity Annual Cr 806
Cash from Investing Activity Annual Cr -725
Cash from Financing Annual Activity Cr 507
Net Cash Flow Annual Cr 588
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 5,842
Fixed Assets Annual Cr 2,854
Total Non Current Assets Annual Cr 3,437
Total Current Assets Annual Cr 5,189
Total Assets Annual Cr 8,626
IndicatorMar 2023
Book Value Per Share Annual Rs 233
ROE Annual % 8
ROCE Annual % 12
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 17

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹1,237.4
32.1 (2.66%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹1,187.52
  • 50 Day
  • ₹1,168.18
  • 100 Day
  • ₹1,120.04
  • 200 Day
  • ₹1,041.77
  • 20 Day
  • ₹1,184.80
  • 50 Day
  • ₹1,170.79
  • 100 Day
  • ₹1,132.27
  • 200 Day
  • ₹998.88

Ipca Laboratories Resistance and Support

PIVOT
₹1,228.25
Resistance
First Resistance 1,254.15
Second Resistance 1,270.90
Third Resistance 1,296.80
RSI 62.85
MFI 78.04
MACD Single Line 2.16
MACD 6.80
Support
First Resistance 1,211.50
Second Resistance 1,185.60
Third Resistance 1,168.85

Ipca Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 733,806 32,558,972 44.37
Week 597,034 19,469,279 32.61
1 Month 352,116 12,415,619 35.26
6 Month 470,220 18,625,407 39.61

Ipca Laboratories Result Highlights

Ipca Laboratories Synopsis

NSE-Medical-Generic Drugs

Ipca Laboratorie is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 5814.62 Cr. and Equity Capital is Rs. 25.37 Cr. for the Year ended 31/03/2023. Ipca Laboratories Ltd. is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1949PLC007837 and registration number is 007837.
Market Cap 31,393
Sales 6,060
Shares in Float 13.70
No of funds 231
Yield 0.17
Book Value 5.36
U/D Vol ratio 1.3
LTDebt / Equity 11
Alpha 0.07
Beta 0.82

Ipca Laboratories

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 46.29%46.29%46.29%46.29%
Mutual Funds 29.25%30.23%30.27%29.94%
Insurance Companies 4.54%4.12%4.26%3.61%
Foreign Portfolio Investors 10.27%9.86%10.05%10.58%
Financial Institutions/ Banks 0.01%
Individual Investors 7.12%7.14%6.98%7.26%
Others 2.53%2.36%2.14%2.32%

Ipca Laboratories Management

Name Designation
Mr. Premchand Godha Executive Chairman
Mr. Ajit Kumar Jain Managing Director
Mr. Pranay Godha Managing Director
Mr. Prashant Godha Executive Director
Mr. Anand T Kusre Independent Director
Dr.(Mrs.) Manisha Premnath Independent Director
Mr. Kamal Kishore Seth Independent Director
Dr. Narendra Mairpady Independent Director

Ipca Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ipca Laboratories Corporate Action

Date Purpose Remarks
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results & Interim Dividend
2023-08-10 Quarterly Results
2023-05-29 Audited Results
2023-02-14 Quarterly Results
Date Purpose Remarks
2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
2021-11-23 INTERIM Rs.8.00 per share(400%)Interim Dividend
Date Purpose Remarks
2022-01-11 Split Rs.0.00 split from Rs. 2/- to Re. 1/-.

Ipca Laboratories FAQs

What is Share Price of Ipca Laboratories ?

Ipca Laboratories share price is ₹1,237 As on 29 March, 2024 | 02:03

What is the Market Cap of Ipca Laboratories ?

The Market Cap of Ipca Laboratories is ₹31393.4 Cr As on 29 March, 2024 | 02:03

What is the P/E ratio of Ipca Laboratories ?

The P/E ratio of Ipca Laboratories is 55.6 As on 29 March, 2024 | 02:03

What is the PB ratio of Ipca Laboratories ?

The PB ratio of Ipca Laboratories is 5.3 As on 29 March, 2024 | 02:03

Q2FY23